Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
China flag China · Delayed Price · Currency is CNY
35.70
+1.41 (4.11%)
Apr 15, 2026, 3:04 PM CST

SHE:002422 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
17,86421,10720,71418,60116,936
Other Revenue
648.53705.65739.64437.62341.23
18,51321,81221,45419,03817,277
Revenue Growth (YoY)
-15.13%1.67%12.69%10.19%4.94%
Cost of Revenue
9,76710,61310,2919,0847,993
Gross Profit
8,74611,20011,1639,9549,284
Selling, General & Admin
4,2464,8015,5925,6575,877
Research & Development
2,2052,1711,9441,7951,737
Other Operating Expenses
154.79110.88184.61192.45150.4
Operating Expenses
6,6417,1567,7567,6947,800
Operating Income
2,1054,0443,4072,2601,484
Interest Expense
-102.84-151.62-361.54-475.22-518.34
Interest & Investment Income
291.83416.62462.47278.81244.03
Currency Exchange Gain (Loss)
-45.5716.8933.36-41.86-2.31
Other Non Operating Income (Expenses)
2.32-170.39-18.95-143.9-21.84
EBT Excluding Unusual Items
2,2514,1553,5221,8781,186
Impairment of Goodwill
-2.41----
Gain (Loss) on Sale of Investments
27.6119.914.679.864.83
Gain (Loss) on Sale of Assets
5.320.812.635.4-7.94
Asset Writedown
-13.03-65.85-58.62-1.93-13.2
Legal Settlements
73.41----
Other Unusual Items
62.08175.0499.621778.38
Pretax Income
2,4044,2853,5802,0681,178
Income Tax Expense
526.62923.4933.79363.7309.5
Earnings From Continuing Operations
1,8773,3622,6471,704868.12
Minority Interest in Earnings
-175.28-426.06-190.531.1234.44
Net Income
1,7022,9362,4561,7051,103
Net Income to Common
1,7022,9362,4561,7051,103
Net Income Growth
-42.03%19.53%44.03%54.67%32.94%
Shares Outstanding (Basic)
1,5911,5781,4531,3981,414
Shares Outstanding (Diluted)
1,5911,5781,5451,4831,414
Shares Change (YoY)
0.77%2.18%4.17%4.91%-1.15%
EPS (Basic)
1.071.861.691.220.78
EPS (Diluted)
1.071.861.591.150.78
EPS Growth
-42.47%16.98%38.26%47.44%34.48%
Free Cash Flow
1,0202,8153,5682,2301,857
Free Cash Flow Per Share
0.641.782.311.501.31
Dividend Per Share
0.5940.7630.8000.6160.426
Dividend Growth
-22.15%-4.63%29.87%44.60%33.63%
Gross Margin
47.24%51.35%52.03%52.29%53.74%
Operating Margin
11.37%18.54%15.88%11.87%8.59%
Profit Margin
9.19%13.46%11.45%8.96%6.38%
Free Cash Flow Margin
5.51%12.90%16.63%11.71%10.75%
EBITDA
3,3975,2494,5963,4162,690
EBITDA Margin
18.35%24.06%21.42%17.94%15.57%
D&A For EBITDA
1,2921,2051,1891,1561,206
EBIT
2,1054,0443,4072,2601,484
EBIT Margin
11.37%18.54%15.88%11.87%8.59%
Effective Tax Rate
21.91%21.55%26.08%17.59%26.28%
Revenue as Reported
18,51321,81221,45419,03817,277
Advertising Expenses
25.09145.44265.58129.59161.8
Source: S&P Global Market Intelligence. Standard template. Financial Sources.